D

DeWitt S. Goodman

Columbia University

Publishes on Retinoids in leukemia and cellular processes, Antioxidant Activity and Oxidative Stress, Cholesterol and Lipid Metabolism. 208 papers and 20.7k citations.

208Publications
20.7kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
DeWitt S. Goodman|Archives of Internal Medicine|1988
Cited by 2.3k

• This report of an expert panel of the National Cholesterol Education Program provides new guidelines for the treatment of high blood cholesterol in adults 20 years of age and over. Total cholesterol levels are classified as follows: &lt;200 mg/dL —"desirable blood cholesterol"; 200 to 239 mg/dL—borderline—high blood cholesterol; ≥240 mg/dL—high blood cholesterol. The guidelines detail which patients should go on to have lipoprotein analysis, and which should receive cholesterol-lowering treatment on the basis of their low density lipoprotein (LDL)—cholesterol levels and status with respect to other coronary heart disease risk factors. Dietary therapy is the primary cholesterol-lowering treatment. The report specifies the LDL-cholesterol levels at which dietary therapy should be started and the goals of therapy, and provides detailed guidance on the nature of the recommended dietary changes. If, after six months of intensive dietary therapy, LDL-cholesterol exceeds specified levels, drug treatment should be considered. (<i>Arch Intern Med</i>1988;148:36-69)

Retinol-binding protein: the transport protein for vitamin A in human plasma
Masamitsu Kanai, Amiram Raz, DeWitt S. Goodman|Journal of Clinical Investigation|1968
Cited by 901Open Access

Vitamin A circulates in human plasma as retinol bound to a specific transport protein. This protein differs from the known low and high density plasma lipoproteins and has a hydrated density greater than 1.21. In order to study this protein, volunteers were injected intravenously with retinol-15-(14)C. Plasma was collected 1-3 days later, and the purification of retinol-binding protein (RBP) was monitored by assaying for (14)C and also by following the fluorescence of the protein-bound retinol. Purification of RBP was effected by the sequence: Cohn fractionation, chromatography on columns of Sephadex G-200 and diethylaminoethyl (DEAE)-Sephadex, preparative polyacrylamide gel electrophoresis, and finally chromatography on Sephadex G-100. These procedures resulted in a preparation of RBP which was at least 98% pure and which had been purified more than 1500-fold. Purified RBP has alpha(1) mobility on electrophoresis and has a molecular weight of approximately 21,000-22,000. There appears to be one binding site for retinol per molecule of RBP. Solutions of RBP are fluorescent (characteristic of retinol) and have ultraviolet absorption spectra with peaks at 330 mmu (resulting from the bound retinol) and at 280 mmu. There are no fatty acid or fatty acyl chains present in purified RBP. The usual concentration of RBP in plasma is of the order of 3-4 mg/100 ml. In plasma, RBP apparently circulates as a complex, together with another, larger protein with prealbumin mobility on electrophoresis. The RBP-prealbumin complex remains intact during Cohn fractionation and during chromatography on Sephadex and on DEAE-Sephadex columns. The complex dissociates during gel electrophoresis, permitting the isolation and subsequent purification of each of the components. The complex is again formed by mixing together solutions of the separated RBP and of prealbumin. Retinol transport in plasma thus appears to involve both a lipid-protein (retinol-RBP) interaction and a protein-protein (RBP-prealbumin) interaction.

The Interaction of Human Serum Albumin with Long-chain Fatty Acid Anions
DeWitt S. Goodman|Journal of the American Chemical Society|1958
Cited by 766

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTThe Interaction of Human Serum Albumin with Long-chain Fatty Acid AnionsDeWitt S. GoodmanCite this: J. Am. Chem. Soc. 1958, 80, 15, 3892–3898Publication Date (Print):August 1, 1958Publication History Published online1 May 2002Published inissue 1 August 1958https://pubs.acs.org/doi/10.1021/ja01548a024https://doi.org/10.1021/ja01548a024research-articleACS PublicationsRequest reuse permissionsArticle Views1266Altmetric-Citations614LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts

Vitamin A and Retinoids in Health and Disease
Franklin H. Epstein, DeWitt S. Goodman|New England Journal of Medicine|1984
Cited by 563

NIGHT blindness was recognized as a disease entity in ancient Egypt. Moreover, literature dating from ancient times to the early 20th century contains comments that appear to indicate recognition of the existence of a dietary substance necessary for night vision. In 1913 McCollum and Davis1 reported that an essential lipid-soluble substance in certain foods promoted growth in rats. They later called this substance "Fat Soluble A," to distinguish it from essential water-soluble nutrients ("Water Soluble B"). Further studies by a number of investigators showed that "Fat Soluble A" (later named vitamin A) not only maintained growth but was capable of . . .

The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma
Frank R. Smith, DeWitt S. Goodman|Journal of Clinical Investigation|1971
Cited by 450Open Access

ABS TR A CT The effects of diseases of the liver, the thyroid, and the kidneys on the retinol-binding protein (RBP)-prealbumin (PA) system responsible for the transport of vitamin A in plasma were examined, using a radial gel diffusion immunoassay for PA and the previously described radioimmunoassay for RBP. Mea- surements were made on plasma samples from 118 nor- mal subjects, 31 patients with cirrhosis, 5 with chronic active hepatitis, 27 with acute viral hepatitis, 14 patients with hyperthyroidism, 7 with hypothyroidism, and 26 patients with chronic renal disease of varying etiologies. In the patients with liver disease, the levels of vitamin A, RBP, and PA were all markedly decreased and were highly significantly correlated over a wide range of con- centrations. Serial samples were available in 19 patients with acute hepatitis; as the disease improved the plasma concentrations of vitamin A, RBP, and PA all increased.